ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,911.66
-0.04%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.645
-0.02%
Brent Oil
83.76
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Cellect Biotechnology Ltd (APOP)

  7. Cellect Biotechnology Ltd (APOP) ニュース

APOP

Cellect Biotechnology (APOP)

Cellect Biotechnology Ltd
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:APOP
日付受信時刻ニュースソース見出しコード企業名
2023/06/2904 : 04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
2023/06/2904 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APOPCellect Biotechnology Ltd
2023/05/1305 : 34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APOPCellect Biotechnology Ltd
2023/05/1005 : 03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
2023/05/1004 : 04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APOPCellect Biotechnology Ltd
2023/05/0906 : 15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APOPCellect Biotechnology Ltd
2023/03/2219 : 02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
2023/03/2019 : 06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APOPCellect Biotechnology Ltd
2023/03/1603 : 40Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:APOPCellect Biotechnology Ltd
2023/03/0406 : 20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APOPCellect Biotechnology Ltd
2023/02/2820 : 14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
2023/02/2820 : 14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
2023/02/2820 : 13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
2023/02/2320 : 05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:APOPCellect Biotechnology Ltd
2023/02/1504 : 41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APOPCellect Biotechnology Ltd
2023/02/1501 : 26Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APOPCellect Biotechnology Ltd
2023/02/1320 : 10Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APOPCellect Biotechnology Ltd
2023/02/0920 : 05Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:APOPCellect Biotechnology Ltd
2023/02/0320 : 03Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:APOPCellect Biotechnology Ltd
2023/01/0323 : 48Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
2023/01/0323 : 45Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
2023/01/0323 : 44Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
2023/01/0323 : 41Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
2023/01/0323 : 38Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APOPCellect Biotechnology Ltd
2022/11/1102 : 45Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
2022/11/1102 : 44Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
2022/11/1101 : 09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APOPCellect Biotechnology Ltd
2022/11/0804 : 46Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
2022/11/0804 : 45Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APOPCellect Biotechnology Ltd
2022/10/2819 : 06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:APOPCellect Biotechnology Ltd
 Showing the most relevant articles for your search:NASDAQ:APOP

最近閲覧した銘柄

TSX
IDG
Indigo Books and Music
ASX
TL1HAA
Telestra
BIT
P1UJ98
NLBNPIT1UJ98 20991231 10...
NASDAQ
PDD
PDD
LSE
0P2N
Ferrovial
BIT
P20GJ9
NLBNPIT20GJ9 20240621 160
BIT
P1VYZ4
NLBNPIT1VYZ4 20991231 69...
BIT
P1Z349
NLBNPIT1Z349 20991231 19...
LSE
0NEZ
Eac Invest A/s
ASX
KLS
Kelsian
BIT
P208Y4
NLBNPIT208Y4 20991231 97...
NASDAQ
HSIC
Henry Schein
COIN
VRTTUSD
Venus Reward Token
BOV
ITTB11L
Itaituba PNE
NYSE
SXT
Sensient Technologies
LSE
0IF3
Eastman Chemical
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有